what does glp-1 stand for The promise and peril of agonists: we do (and don't) know as of August 2024 GLP-1 receptor agonists | How
Description
& Abitbol, A
News-Medical, viewed 18 July 2026, Suggested Reading Sign in to keep reading We're committed to providing free access to quality science
doi: 10.1007/978-3-211-79280-3_949 81 NCT06864026
GLP-1 receptor agonists are MHRA-licensed prescription medicines with extensive clinical trial evidence for type 2 diabetes and obesity management
The Bigger Picture: Organ Protection, Not Just Sugar Control If you have existing heart disease or kidney concerns alongside diabetes, this transition carries extra weight
Limitations and future perspective The use of GLP-1RAs is predicted to increase in treating diabetes, neurological disorders, and IBD
